| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), BCRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.34M | $13.00M | - | |
| CFO | 268.7K | - | - | |
| Other | 205.2K | - | - | |
| Dir | 109.6K | $1.06M | - | |
| Dir | 80.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2016 | Baker Bros. Advisors LP59 | 10% Owner | Buy | 344,895 | $7.28 | $2,510,143.35 | +2.9% | |
| Dec 21, 2015 | Staab Thomas R II | Senior Vice President And CFO | Sell | 3,052 | $10.86 | $33,144.72 | -2.2% | |
| Dec 17, 2015 | Staab Thomas R II | Senior Vice President And CFO | Sell | 3,000 | $10.49 | $31,470.00 | -2.1% |